Financhill
Sell
15

EGRX Quote, Financials, Valuation and Earnings

Last price:
$0.25
Seasonality move :
-10.89%
Day range:
$0.25 - $0.33
52-week range:
$0.10 - $3.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.01x
Volume:
5.1K
Avg. volume:
5.3K
1-year change:
-68.75%
Market cap:
$3.2M
Revenue:
--
EPS (TTM):
--

Earnings Data

Next earnings date for EGRX
--
Most recent earnings per share
$0.39
Missed by $0.75
(Aug 8/2023)
Consensus Estimate
$1.14
(Aug 8/2023)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EGRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/13/2024 Q4 -- -- -- $1.07 --
11/09/2023 Q3 -- -- -- $1.09 --
08/08/2023 Q2 -- -- $0.39 $1.14 -$0.75
05/09/2023 Q1 -- -- $0.44 $1.05 -$0.61
03/13/2023 Q4 -- -- $0.62 $0.83 -$0.21
11/07/2022 Q3 -- -- -$0.54 $0.91 -$1.45
08/09/2022 Q2 -- -- -$0.74 $3.36 -$4.10
05/09/2022 Q1 -- -- $3.41 $3.66 -$0.25
03/07/2022 Q4 -- -- -$0.48 $0.94 -$1.42
11/09/2021 Q3 -- -- -$0.43 $0.83 -$1.26
08/09/2021 Q2 -- -- $0.27 $0.80 -$0.53
05/10/2021 Q1 -- -- -$0.03 $0.73 -$0.76
03/02/2021 Q4 -- -- $0.59 -$0.20 $0.79
11/02/2020 Q3 -- -- $0.51 $0.30 $0.22
08/10/2020 Q2 -- -- -$0.02 $0.24 -$0.26
05/11/2020 Q1 -- -- -$0.21 $0.57 -$0.78
03/02/2020 Q4 -- -- $0.07 $0.49 -$0.42
11/12/2019 Q3 -- -- -$0.17 $0.43 -$0.60
08/08/2019 Q2 -- -- $0.48 $0.83 -$0.35
05/07/2019 Q1 -- -- $0.62 $0.73 -$0.11
02/28/2019 Q4 -- -- $0.86 -- --
11/01/2018 Q3 -- -- $0.91 -- --
08/07/2018 Q2 -- -- $0.17 -- --
05/10/2018 Q1 -- -- $0.17 -- --
02/26/2018 Q4 -- -- $0.58 -- --
11/08/2017 Q3 -- -- $0.98 -- --
08/09/2017 Q2 -- -- $0.28 -- --
05/08/2017 Q1 -- -- $1.42 -- --
03/01/2017 Q4 -- -- $3.52 -- --
11/09/2016 Q3 -- -- $0.73 -- --
08/09/2016 Q2 -- -- $0.80 -- --
05/09/2016 Q1 -- -- -$0.06 -- --

Eagle Pharmaceuticals, Inc. Earnings Questions

  • How Much did Eagle Pharmaceuticals, Inc. Generate in Revenue Last Quarter?

    Eagle Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Eagle Pharmaceuticals, Inc. Beat Earnings Last Quarter?

    Eagle Pharmaceuticals, Inc. announced earnings per share of $0.39 which represents a miss of analyst forecast a $1.14 per share.

  • Is Eagle Pharmaceuticals, Inc. Profitable?

    Eagle Pharmaceuticals, Inc. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Eagle Pharmaceuticals, Inc. EPS Next Year?

    Eagle Pharmaceuticals, Inc.'s earnings are forecast to grow from -- per share to $4.42 per share next year representing an increase of 71.8%.

  • When is Eagle Pharmaceuticals, Inc.'s Earnings Date?

    Currently, Eagle Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on May 2, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How Big Will the SpaceX IPO Be?
How Big Will the SpaceX IPO Be?

Operated up to now as a private business, SpaceX will…

Where Will ISRG Stock Be in 5 Years?
Where Will ISRG Stock Be in 5 Years?

Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…

Is Kratos Stock a Good Investment?
Is Kratos Stock a Good Investment?

UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Sell
50
Is GOOGL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 42x

Alerts

Sell
40
GDXU alert for Jan 31

MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is down 38.85% over the past day.

Sell
34
PFSI alert for Jan 31

PennyMac Financial Services, Inc. [PFSI] is down 33.21% over the past day.

Sell
40
SHNY alert for Jan 31

MicroSectors Gold 3X Leveraged ETN [SHNY] is down 31.56% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock